Financials
- Market Capitalization 2.17 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-18.43
Relación precio/flujo de caja
10.57
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1943 | ZYME Zymeworks Inc. - Common Stock | 31.05 USD | +4.65% | +5.90% | +41.46% | +75.03% | 2.20 B USD | ||
| 1952 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | +1.50% | -1.09% | +10.67% | +36.55% | 2.17 B USD | ||
| 1960 | ADMA ADMA Biologics Inc - Common Stock | 9.51 USD | +1.93% | -0.94% | +10.71% | -44.29% | 2.13 B USD | ||
| 1961 | ZBIO Zenas BioPharma, Inc. - Common Stock | 33.09 USD | +3.47% | +0.15% | +3.15% | +25.06% | 2.16 B USD |